NCT00440323View on ClinicalTrials.gov

Disturbed Sleep Model Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 5, 2007

Primary Completion Date

July 3, 2007

Study Completion Date

July 3, 2007

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

SB-649868

SB-649868 tablets will be available with dose strength of 5 and 25 mg.

DRUG

Zolpidem

Zolpidem capsules will be available with dose strength of 10 mg.

DRUG

Placebo

Placebo tablet matching SB-649868 or Placebo capsule matching Zolpidem will be available.

Trial Locations (1)

GU2 7XP

GSK Investigational Site, Guildford

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY